Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Axial mesodermal dysplasia spectrum is a rare developmental defect during embryogenesis syndrome characterized by congenital manifestations of both oculo-auriculo-vertebral spectrum and caudal regression sequence. Phenotype is highly variable but patients typically present facial dysmorphism (incl. asymmetry, hypertelorism), auricular abnormalities (e.g. preauricular tags, microtia, absence of middle ear ossicles), skeletal malformations (hemivertebrae, hip dislocation, sacral agenesis/dysplasia, talipes equinovarus, flexion deformity of lower limbs), cardiac defects (dextrocardia, septal defects), renal and genitourinary anomalies (such as renal agensis/dysplasia, abnormal external genitalia, cryptorchidia), as well as anal anomalies such as anal atresia and rectovesical fistula.
Biomarker and diagnostic research for axial mesodermal dysplasia spectrum has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for axial mesodermal dysplasia spectrum.
226 publications have been identified in PubMed for axial mesodermal dysplasia spectrum. Research spans Review / Meta-Analysis (45%), Basic Science / Preclinical (34%), and Case Report / Case Series (8%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 101 | 45% |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 3:44 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research
76 |
34% |
Patient case studies | 18 | 8% |
Disease patterns and progression | 15 | 7% |
Clinical study results | 11 | 5% |
Testing and diagnosis research | 3 | 1% |
Other research | 1 | 0% |
New treatment approaches | 1 | 0% |
Woessner NM (2026). [PMID: 41482192](https://pubmed.ncbi.nlm.nih.gov/41482192/). *Immunol Lett*. [Review / Meta-Analysis]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology*. [Review / Meta-Analysis]
Buel KL (2026). [PMID: 41569909](https://pubmed.ncbi.nlm.nih.gov/41569909/). *FP Essent*. [Review / Meta-Analysis]
Yin Y (2026). [PMID: 41447534](https://pubmed.ncbi.nlm.nih.gov/41447534/). *Cell Rep*. [Basic Science / Preclinical]
Bassan VL (2026). [PMID: 41344282](https://pubmed.ncbi.nlm.nih.gov/41344282/). *Thromb Res*. [Basic Science / Preclinical]
Khouili SC (2026). [PMID: 42172306](https://pubmed.ncbi.nlm.nih.gov/42172306/). *Sci Immunol*. [Basic Science / Preclinical]
Guerra L (2026). [PMID: 41734064](https://pubmed.ncbi.nlm.nih.gov/41734064/). *Cell Rep*. [Basic Science / Preclinical]
Dupré L (2026). [PMID: 40931027](https://pubmed.ncbi.nlm.nih.gov/40931027/). *Nat Rev Immunol*. [Review / Meta-Analysis]
Maurice NJ (2026). [PMID: 41667619](https://pubmed.ncbi.nlm.nih.gov/41667619/). *Nat Immunol*. [Basic Science / Preclinical]
Chen L (2026). [PMID: 41412235](https://pubmed.ncbi.nlm.nih.gov/41412235/). *J Ethnopharmacol*. [Basic Science / Preclinical]